info@marketresearchfuture.com   📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Nausea Medicine Market Analysis

ID: MRFR//3105-CR | 104 Pages | Author: Rahul Gotadki| February 2021

In recent years, the market trends in the nausea medicine sector have witnessed notable shifts, reflecting both advancements in pharmaceutical research and evolving consumer preferences. One prominent trend is the growing demand for natural and herbal remedies. With increasing awareness about the potential side effects of synthetic medications, consumers are turning towards plant-based alternatives. Products containing ingredients like ginger, peppermint, and lemon balm have gained traction due to their perceived safety and efficacy.

Moreover, there is a rising emphasis on convenience and ease of use in nausea medicine products. This has led to the development of innovative formulations such as dissolvable tablets, chewable gums, and wearable patches. These convenient delivery methods offer consumers more flexibility in managing their symptoms, especially in situations where swallowing pills may be challenging.

Another significant trend in the nausea medicine market is the expansion of options for specific patient populations. For instance, there has been a growing focus on developing pediatric-friendly formulations to address nausea and vomiting in children. These formulations often come in child-friendly flavors and dosage forms, making them more appealing and easier to administer to young patients.

Additionally, there is a noticeable shift towards personalized medicine within the nausea treatment landscape. Advances in genetic testing and pharmacogenomics have enabled healthcare providers to tailor treatment plans based on individual genetic makeup and drug metabolism profiles. This personalized approach not only improves treatment outcomes but also minimizes the risk of adverse reactions and maximizes the efficacy of nausea medications.

Furthermore, the global pandemic has had a profound impact on the nausea medicine market. The widespread adoption of telemedicine and remote healthcare services has transformed how patients access and receive treatment for nausea-related conditions. Virtual consultations and digital platforms have become integral parts of the patient journey, providing convenient access to healthcare professionals and medication management resources.

In terms of market dynamics, mergers and acquisitions have played a significant role in shaping the landscape of the nausea medicine market. Pharmaceutical companies are increasingly seeking strategic partnerships and collaborations to expand their product portfolios and leverage synergies in research and development. This consolidation trend is expected to continue as companies strive to enhance their competitive position and capitalize on emerging opportunities in the market.

Moreover, regulatory developments and government policies also influence market trends in the nausea medicine sector. Stringent regulations regarding the approval and marketing of pharmaceutical products drive innovation and quality standards within the industry. Additionally, factors such as pricing pressures, reimbursement policies, and healthcare reforms impact market dynamics and the availability of nausea medications to patients.

Covered Aspects:

Report Attribute/Metric Details
Segment Outlook Type, Mode of Administration, Indication, and Distribution Channel

Global Nausea Medicine Market Overview 


Nausea Medicine Market Size was valued at USD 3.42 Billion in 2023. The Global Nausea Medicine industry is projected to grow from USD 3.66 Billion in 2024 to USD 6.24 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 7.20% during the forecast period (2024 - 2032).Nausea medicines are those that have the ability to treat conditions such as nausea and vomiting. The growing cases of cancer rise in gastrointestinal diseases, and increasing geriatric population, sedentary lifestyle and unhealthy diet, are driving the global nausea medicine market. However, a high preference for home remedies is expected to hamper the growth of this market during the forecast period. Nevertheless, collaborations between large drug manufacturing companies and small companies are likely to set a lucrative opportunity for the growth of this market in the near future.


Nausea Medicine Market Dynamics


Cancer has a major impact on society in the United States and across the world. According to the National Cancer Institute, in 2020, roughly 1.8 Million people will be diagnosed with cancer in the United States. An estimated 276,480 women and 2,620 men will be diagnosed with breast cancer, which makes it the most common cancer diagnosis. According to Cancer Research UK, in females in the UK, there were more than 179,000 new cancer cases in 2017, and in males in the UK, there were around 187,000 new cancer cases in 2017. Such a rising number of people being affected by different types of cancer is driving the growth of the nausea medicine market. Chemotherapy is one of the standard treatments used to deal with cancer and is also accompanied by side effects of nausea and vomiting. Chemotherapy-induced vomiting and early stage of pregnancy require nausea medicine throughout the therapy. Thus, nausea medicine would witness an increase in sales due to growing cases of cancer during the forecast period.


Nausea Medicine Market Segment Insights


Global Nausea Medicine Market has been segmented By Type, Mode of Administration, Indication, and Distribution Channel.


Nausea Medicine Type Insights


The nausea medicine market, on the basis of type, has been segmented into antagonists, cannabinoids, antihistamines, and others. 


Nausea Medicine Mode of Administation Insights


The nausea medicine market, based on the mode of administration, is divided into oral, intravenous, and others. The nausea medicine market, based on indication, is divided into oncology, gastroesophageal reflux disease (GERD), motion sickness, and others. The nausea medicine market, based on distribution channel, is divided into hospital/retail pharmacies and online.


By indication, the oncology segment held the largest share of 39.84% in 2019 owing to an increasing number of patients experiencing nausea associated with chemotherapeutic drug use.


Nausea Medicine Regional Insights


Global Nausea Medicine Market, based on region, has been divided into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas is likely to dominate the global nausea medicine market. This large share can be attributed to the presence of major manufacturers, rising awareness about early disease diagnosis, and the rising prevalence of gastrointestinal diseases.    


The European market is the second-largest market for nausea medicine. Factors such as a boost in the biopharmaceutical sector in the European region, improving economies, high disposable income per individual, and increased healthcare spending are driving the growth of the market in this region.  


The market in Asia-Pacific is expected to register a significant growth rate during the forecast period owing to growing awareness about diseases, government support to improve the healthcare sector, and rising geriatric population.


The nausea medicine market in the Middle East & Africa is projected to show gradual growth during the forecast period. In this region, the Middle East is anticipated to dominate owing to the number of cancer populations and high incidences of gastroenteritis and other gastrointestinal diseases.


Nausea Medicine Market Key Players


The Prominent Players in the Global Nausea Medicine Market are



  • Novartis AG (Switzerland)

  • Merck & Co., Inc. (US)

  • F. Hoffmann-La Roche Ltd (Switzerland)

  • GlaxoSmithKline PLC (UK)

  • Pfizer Inc. (US)

  • Sanofi S.A. (France)

  • Mylan NV (US)

  • AstraZeneca (UK)

  • Cipla Inc. (India)


Some of the key strategies followed by players operating in the global market were innovation, product development, expansion, and acquisition & mergers.



  • In January 2019, GlaxoSmithKline plc acquired TESARO, Inc. (US). This acquisition helped the company to strengthen its nausea products portfolio.


Nausea Medicine Market Segmentation


 Nausea Medicine Type Outlook



  • Antagonists

  • Antihistamines

  • Cannabinoids

  • Others


Nausea Medicine Mode of Administration Outlook



  • Intravenous

  • Oral

  • Transdermal


 Nausea Medicine Indication Outlook



  • Oncology

  • Gastroesophageal Reflux Disease (GERD)

  • Motion Sickness And Seasickness

  • Others


Nausea Medicine Distribution Channel Outlook



  • Hospitals Pharmacy/ Retail Pharmacy

  • Online


Nausea Medicine Region Outlook



  • Americas

    • North America

      • US

      • Canada



    • South America



  • Europe

    • Western Europe

      • Germany

      • France

      • K

      • Italy

      • Spain

      • Rest of Western Europe



    • Eastern Europe



  • Asia-Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Rest of Asia-Pacific



  • Middle East & Africa

    • Middle East

    • Africa




Available Additional Customizations



  • Additional 5 Company Profiles


Intended Audience



  • Nausea Medicine Manufacturers

  • Nausea Medicine Suppliers

  • Medical Research Laboratories

  • Research and Development (R&D) Companies

  • Market Research and Consulting Service Providers

  • Potential Investors

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.